Abbott Laboratories ABT
Quarterly report 2024-Q3
added 10-31-2024
Country |
USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
CEO |
Mr. Robert Ford |
Employees in the company |
107 000 |
Shares |
1.74 B |
Market Cap[1] |
$ 201 B |
EBITDA (LTM) |
$ 8.33 B |
P/E (LTM) |
35.43 |
P/S (LTM) |
4.8 |
EPS (LTM) |
3.2 |
Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.
Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.
Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.
Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.